Epiregulin


Protein found in humans
EREG
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

1K36, 1K37, 5E8D

Identifiers
AliasesEREG, EPR, ER, Ep, epiregulin
External IDsOMIM: 602061 MGI: 107508 HomoloGene: 1097 GeneCards: EREG
Gene location (Human)
Chromosome 4 (human)
Chr.Chromosome 4 (human)[1]
Chromosome 4 (human)
Genomic location for EREG
Genomic location for EREG
Band4q13.3Start74,365,145 bp[1]
End74,388,749 bp[1]
Gene location (Mouse)
Chromosome 5 (mouse)
Chr.Chromosome 5 (mouse)[2]
Chromosome 5 (mouse)
Genomic location for EREG
Genomic location for EREG
Band5|5 E1Start91,222,481 bp[2]
End91,241,505 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • amniotic fluid

  • human penis

  • cervix epithelium

  • oral cavity

  • bone marrow cells

  • skin of abdomen

  • gums

  • monocyte

  • gallbladder

  • vulva
Top expressed in
  • conjunctival fornix

  • esophagus

  • belly cord

  • skin of back

  • ileum

  • cornea

  • epidermis

  • left colon

  • lip

  • jejunum
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • epidermal growth factor receptor binding
  • protein binding
  • growth factor activity
  • protein tyrosine kinase activity
  • phosphatidylinositol-4,5-bisphosphate 3-kinase activity
Cellular component
  • integral component of membrane
  • membrane
  • plasma membrane
  • integral component of plasma membrane
  • extracellular region
  • intracellular anatomical structure
  • extracellular space
  • clathrin-coated vesicle membrane
Biological process
  • luteinizing hormone signaling pathway
  • positive regulation of epidermal growth factor-activated receptor activity
  • cell differentiation
  • ovarian cumulus expansion
  • negative regulation of smooth muscle cell differentiation
  • positive regulation of cytokine production
  • cytokine-mediated signaling pathway
  • positive regulation of fibroblast proliferation
  • cell-cell signaling
  • anatomical structure morphogenesis
  • response to peptide hormone
  • wound healing
  • mRNA transcription
  • female meiotic nuclear division
  • primary follicle stage
  • keratinocyte differentiation
  • MAPK cascade
  • multicellular organism development
  • positive regulation of DNA replication
  • keratinocyte proliferation
  • oocyte maturation
  • angiogenesis
  • positive regulation of cell population proliferation
  • positive regulation of innate immune response
  • negative regulation of epithelial cell proliferation
  • animal organ morphogenesis
  • positive regulation of phosphorylation
  • negative regulation of transcription, DNA-templated
  • positive regulation of mitotic nuclear division
  • ovulation
  • positive regulation of cell division
  • negative regulation of cell population proliferation
  • positive regulation of smooth muscle cell proliferation
  • positive regulation of protein kinase activity
  • ERBB2 signaling pathway
  • regulation of cell motility
  • epidermal growth factor receptor signaling pathway
  • peptidyl-tyrosine phosphorylation
  • phosphatidylinositol phosphate biosynthetic process
  • positive regulation of protein kinase B signaling
  • signal transduction
  • negative regulation of epidermal growth factor receptor signaling pathway
  • membrane organization
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

2069

13874

Ensembl

ENSG00000124882

ENSMUSG00000029377

UniProt

O14944

Q61521

RefSeq (mRNA)

NM_001432

NM_007950

RefSeq (protein)

NP_001423

NP_031976

Location (UCSC)Chr 4: 74.37 – 74.39 MbChr 5: 91.22 – 91.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Epiregulin (EPR) is a protein that in humans is encoded by the EREG gene.[5][6]

Structure

Epiregulin consists of 46 amino acid residues. Its secondary structure contains approximately 30 percent of β-sheet in the strand.[7] Some of the residues form loops and turns due to the hydrogen bonding.[7] The percentage of β-sheet in epiregulin depends on the domain and the secondary structures that they occupy. The polymeric molecules of epiregulin has the formula weight of 5280.1 g/mol with a polypeptide(L), a polymer type.[7]

Structural motifs in most proteins have typical connections in an all β motif. Meaning that the polypeptide chains do not make a crossover connection or in so far as this type of connection has not been observed. Epiregulin is one of the proteins that occupies a typical connection in all β motif. Furthermore, as the structure of epiregulin forms a chain in an all β motif, it also forms β hairpin structural motif. A β hairpin is when the two adjacent anti-parallel β strands connected by a β-turn.

Function

Epiregulin is a member of the epidermal growth factor family. Epiregulin can function as a ligand of epidermal growth factor receptor (EGFR), as well as a ligand of most members of the ERBB (v-erb-b2 oncogene homolog) family of tyrosine-kinase receptors.[6] The secondary structure at the C-terminus epiregulin is different from other epidermal growth factor family ligands because of the lack of hydrogen bonds. The structural difference at the C-terminus may provide an explanation for the reduced binding affinity of epiregulin to the ERBB receptors.[7]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000124882 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000029377 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Toyoda H, Komurasaki T, Uchida D, Morimoto S (August 1997). "Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family". Biochem. J. 326 (1): 69–75. doi:10.1042/bj3260069. PMC 1218638. PMID 9337852.
  6. ^ a b "Entrez Gene: epiregulin".
  7. ^ a b c d Sato K, Nakamura T, Mizuguchi M, Miura K, Tada M, Aizawa T, Gomi T, Miyamoto K, Kawano K (October 2003). "Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity". FEBS Lett. 553 (3): 232–8. doi:10.1016/s0014-5793(03)01005-6. PMID 14572630. S2CID 24761378.

Further reading

  • Yamamoto T, Akisue T, Marui T, et al. (2004). "Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma". Anticancer Res. 24 (3b): 2007–10. PMID 15274392.
  • Li S, Takeuchi F, Wang JA, et al. (2008). "Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas". Proc. Natl. Acad. Sci. U.S.A. 105 (9): 3539–44. Bibcode:2008PNAS..105.3539L. doi:10.1073/pnas.0712397105. PMC 2265180. PMID 18292222.
  • Cho MC, Choi HS, Lee S, et al. (2008). "Epiregulin expression by Ets-1 and ERK signaling pathway in Ki-ras-transformed cells". Biochem. Biophys. Res. Commun. 377 (3): 832–7. doi:10.1016/j.bbrc.2008.10.053. PMID 18948081.
  • Lindvall C, Hou M, Komurasaki T, et al. (2003). "Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene". Cancer Res. 63 (8): 1743–7. PMID 12702554.
  • Morita S, Shirakata Y, Shiraishi A, et al. (2007). "Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members". Mol. Vis. 13: 2119–28. PMID 18079685.
  • Freimann S, Ben-Ami I, Dantes A, et al. (2004). "EGF-like factor epiregulin and amphiregulin expression is regulated by gonadotropins/cAMP in human ovarian follicular cells". Biochem. Biophys. Res. Commun. 324 (2): 829–34. doi:10.1016/j.bbrc.2004.09.129. PMID 15474502.
  • Ben-Ami I, Armon L, Freimann S, et al. (2009). "EGF-like growth factors as LH mediators in the human corpus luteum". Hum. Reprod. 24 (1): 176–84. doi:10.1093/humrep/den359. PMID 18835871.
  • Shigeishi H, Higashikawa K, Hiraoka M, et al. (2008). "Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas". Oncol. Rep. 19 (6): 1557–64. doi:10.3892/or.19.6.1557. PMID 18497965.
  • Taylor DS, Cheng X, Pawlowski JE, et al. (1999). "Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin". Proc. Natl. Acad. Sci. U.S.A. 96 (4): 1633–8. Bibcode:1999PNAS...96.1633T. doi:10.1073/pnas.96.4.1633. PMC 15542. PMID 9990076.
  • Zhang J, Iwanaga K, Choi KC, et al. (2008). "Intratumoral epiregulin is a marker of advanced disease in non-small cell lung cancer patients and confers invasive properties on EGFR-mutant cells". Cancer Prev Res (Phila). 1 (3): 201–7. doi:10.1158/1940-6207.CAPR-08-0014. PMC 3375599. PMID 19138957.
  • Draper BK, Komurasaki T, Davidson MK, Nanney LB (2003). "Epiregulin is more potent than EGF or TGFalpha in promoting in vitro wound closure due to enhanced ERK/MAPK activation". J. Cell. Biochem. 89 (6): 1126–37. doi:10.1002/jcb.10584. PMID 12898511. S2CID 24643892.
  • Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP (January 2008). "ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis". Ann. Oncol. 19 (1): 73–80. doi:10.1093/annonc/mdm431. PMID 17962208.
  • Ben-Ami I, Freimann S, Armon L, et al. (2006). "PGE2 up-regulates EGF-like growth factor biosynthesis in human granulosa cells: new insights into the coordination between PGE2 and LH in ovulation". Mol. Hum. Reprod. 12 (10): 593–9. doi:10.1093/molehr/gal068. PMID 16888076.
  • Takahashi M, Hayashi K, Yoshida K, et al. (2003). "Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells". Circulation. 108 (20): 2524–9. doi:10.1161/01.CIR.0000096482.02567.8C. PMID 14581411. S2CID 8012969.
  • Lasky-Su J, Neale BM, Franke B, et al. (2008). "Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations". Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (8): 1345–54. doi:10.1002/ajmg.b.30867. PMID 18821565. S2CID 9493672.
  • Gupta GP, Nguyen DX, Chiang AC, et al. (2007). "Mediators of vascular remodelling co-opted for sequential steps in lung metastasis". Nature. 446 (7137): 765–70. Bibcode:2007Natur.446..765G. doi:10.1038/nature05760. PMID 17429393. S2CID 4420038.
  • Shirakata Y, Komurasaki T, Toyoda H, et al. (2000). "Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes". J. Biol. Chem. 275 (8): 5748–53. doi:10.1074/jbc.275.8.5748. PMID 10681561.
  • v
  • t
  • e
  • 1k36: NMR Structure of human Epiregulin
    1k36: NMR Structure of human Epiregulin
  • 1k37: NMR Structure of human Epiregulin
    1k37: NMR Structure of human Epiregulin

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  • v
  • t
  • e
Angiopoietin
  • Kinase inhibitors: Altiratinib
  • CE-245677
  • Rebastinib
CNTF
EGF (ErbB)
EGF
(ErbB1/HER1)
ErbB2/HER2
  • Agonists: Unknown/none
ErbB3/HER3
ErbB4/HER4
FGF
FGFR1
FGFR2
  • Antibodies: Aprutumab
  • Aprutumab ixadotin
FGFR3
FGFR4
Unsorted
HGF (c-Met)
IGF
IGF-1
  • Kinase inhibitors: BMS-754807
  • Linsitinib
  • NVP-ADW742
  • NVP-AEW541
  • OSl-906
IGF-2
  • Antibodies: Dusigitumab
  • Xentuzumab (against IGF-1 and IGF-2)
Others
  • Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
  • Trofinetide
LNGF (p75NTR)
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: LEVI-04 (p75NTR-Fc)
PDGF
RET (GFL)
GFRα1
GFRα2
GFRα3
GFRα4
Unsorted
  • Kinase inhibitors: Agerafenib
SCF (c-Kit)
TGFβ
  • See here instead.
Trk
TrkA
  • Negative allosteric modulators: VM-902A
  • Aptamers: Against NGF: RBM-004
  • Decoy receptors: ReN-1820 (TrkAd5)
TrkB
TrkC
VEGF
Others


Stub icon

This article on a gene on human chromosome 4 is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e